WO2022214876A2 - Personal hygiene wipe with integral urine glucose detection feature - Google Patents
Personal hygiene wipe with integral urine glucose detection feature Download PDFInfo
- Publication number
- WO2022214876A2 WO2022214876A2 PCT/IB2022/000198 IB2022000198W WO2022214876A2 WO 2022214876 A2 WO2022214876 A2 WO 2022214876A2 IB 2022000198 W IB2022000198 W IB 2022000198W WO 2022214876 A2 WO2022214876 A2 WO 2022214876A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wipe
- glucose
- urine
- composition
- hygiene
- Prior art date
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 39
- 239000008103 glucose Substances 0.000 title claims abstract description 37
- 210000002700 urine Anatomy 0.000 title claims abstract description 36
- 238000001514 detection method Methods 0.000 title abstract description 7
- 239000000758 substrate Substances 0.000 claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 238000004140 cleaning Methods 0.000 claims abstract description 5
- 239000000126 substance Substances 0.000 claims abstract description 5
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract 2
- 238000001035 drying Methods 0.000 claims abstract 2
- 238000005470 impregnation Methods 0.000 claims abstract 2
- 235000019420 glucose oxidase Nutrition 0.000 claims description 9
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 102000016938 Catalase Human genes 0.000 claims description 7
- 108010053835 Catalase Proteins 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 6
- 239000005711 Benzoic acid Substances 0.000 claims description 4
- 229920001131 Pulp (paper) Polymers 0.000 claims description 4
- 235000010233 benzoic acid Nutrition 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 3
- 229920000297 Rayon Polymers 0.000 claims description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims description 3
- 229920000728 polyester Polymers 0.000 claims description 3
- 229930002877 anthocyanin Natural products 0.000 claims description 2
- 235000010208 anthocyanin Nutrition 0.000 claims description 2
- 239000004410 anthocyanin Substances 0.000 claims description 2
- 150000004636 anthocyanins Chemical class 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 abstract description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 18
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 102000004877 Insulin Human genes 0.000 description 9
- 108090001061 Insulin Proteins 0.000 description 9
- 229940125396 insulin Drugs 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 108010015776 Glucose oxidase Proteins 0.000 description 6
- 239000004366 Glucose oxidase Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229940116332 glucose oxidase Drugs 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000012216 screening Methods 0.000 description 5
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 210000000496 pancreas Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 208000019206 urinary tract infection Diseases 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000009535 clinical urine test Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 229950006191 gluconic acid Drugs 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 206010018473 Glycosuria Diseases 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- -1 iodide ions Chemical class 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000003899 penis Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010027525 Microalbuminuria Diseases 0.000 description 1
- 229920000426 Microplastic Polymers 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010046555 Urinary retention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 230000035780 glucosuria Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002910 solid waste Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B10/007—Devices for taking samples of body liquids for taking urine samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/528—Atypical element structures, e.g. gloves, rods, tampons, toilet paper
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B2010/0003—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements including means for analysis by an unskilled person
- A61B2010/0006—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements including means for analysis by an unskilled person involving a colour change
Definitions
- Diabetic Toilet Paper/Wipe is a toilet paper for female diabetics, used after urinating which will change color if the user has abnormal glucose levels in their urine. It is a rapid glucose test in toilet paper form”. Said application is incorporated herein by reference.
- the present invention generally relates to the fields of bathroom hygiene and self-administered medical screening. More particularly, the invention is directed to a personal hygiene wipe with an integral urine glucose detection feature. BACKGROUND OF THE INVENTION
- Proper bathroom hygiene is especially important for women, given the female urethral opening’s close proximity to the rectum and the absence of a female appendage to aim the flow of urine away from the body as is the case with males. If the vaginal area is not cleaned after urination, urine droplets will accumulate in the pubic region and be transferred to undergarments. In addition to causing odor, the accumulation of urine creates a breeding ground for bacteria which increases the risk of a urinary tract infection in females.
- Toilet paper is readily available virtually everywhere, biodegrades quickly and efficiently, and does not damage pipelines, sewage systems, and water treatment centers.
- toilet paper While traditional toilet paper has its advantages, it has disadvantages as well. A noted disadvantage is that in order to achieve a thorough cleaning, many users use more paper than necessary. In addition, the white color of toilet paper is often the result of it being bleached with chlorine which can produce a harmful chemical by- product known as dioxin.
- wipes are increasingly being used as an alternative to toilet paper.
- wipes come in a variety of sizes, shape and constructions depending on brand and marketing strategy.
- Wipes have the advantage of being sturdier than toilet paper and their moistness helps in the cleaning process which results in a greater sense of feeling clean.
- poorly designed flushable wipes create problems for sewer pipes and water treatment systems and for the environment as well.
- Fatbergs are larges masses of non-biodegradable solid waste in a sewage system. They are formed of congealed fat and personal hygiene products that have been flushed down toilets.
- plastic is a common material used to make many flushable wipes.
- the wipes break down after being flushed down the toilet or otherwise discarded, they release microplastics into the water or ground which find their way into the food system and ultimately into the human body.
- the present invention also relates to the field of self- administered medical screening.
- Health care has many stakeholders, including patients, healthcare provides, insurance companies and of course governments. In the United States, the majority of health care services are delivered through private entities as the U.S. does not have a universal health care system. In many cases, governments ultimately bear a great deal of the cost of health care. Through its regulatory powers, governments also control many aspects of health care accessibility and delivery.
- vigilance of health care needs is increasingly being placed on individuals through better diet, more physical exercise and more attention to the signs and signals that the human body provides that indicate a potential health care problem.
- high blood pressure is the body’s way of signaling that one’s cardiovascular system is in need of attention.
- a rapid heart rate that is unrelated to physical exercise and an irregular heart beat are others.
- One’s blood chemistry is particular informing as to a person’s state of health.
- the kidneys remove fluids, waste products and other substances from the blood.
- Urinalysis is especially important in detecting urinary tract infections, chronic kidney disease and in monitoring diabetes.
- Diabetes is a chronic health condition that affects how the human body turns food into energy.
- the stomach breaks down most of the food (Block 101) we eat into sugar, i.e., glucose.
- the stomach and small intestines absorb the glucose and then releases it into bloodstream 104.
- Bloodstream 104 carries the glucose to the cells (Block 107) of the body for immediate conversion to energy if energy is currently needed.
- Block 107 is a representative cell of all of the cells in the body for purposes of this explanation.
- the glucose is stored in the body (Block 106) until it is needed by the cells in order to produce energy.
- the pancreas (Block 105) monitors the bloodstream and produces insulin in proportion to the amount of glucose present in the bloodstream. As shown in Figure 1, insulin is the trigger which controls switch 108 inside the cell that allow glucose from the bloodstream to actually enter the cell for conversion to energy. Without insulin, the switch does not open and no glucose is allowed to enter the cell.
- Block 107 is a representative of all cells in the human body, thus each cell has a corresponding switch 108.
- pancreas When the pancreas does not make a sufficient amount of insulin or the body cannot use all of the insulin the pancreas produces, the excess glucose, i.e., blood sugar, remains in bloodstream 104. This condition is known as diabetes and can lead to severe medication complications if not treated.
- Type 1 diabetes There are two primary types of diabetes, Type 1 and Type 2. People with Type 1 diabetes do not produce insulin and people with Type 2 diabetes do not respond to insulin as well as they should. Diabetes treatment regiments often require constant monitoring of blood sugar. An analysis of the blood is often used for this purpose. Such an analysis usually requires a visit to a doctor’s office or to a lab for blood to be drawn and analyzed. There are also over the counter consumer grade blood sugar monitors that can be purchased as well. Analysis of the urine can also be used to monitor a diabetic condition. One such urine test measures the amount of a protein in the urine called microalbuminuria. This test detects when small amounts of albumin, the main protein in the blood, has found its way into the urine. This condition is indictive of kidney disease which can lead to kidney damage and eventually to kidney failure. Thus, the presence of albumin in the urine suggest that the kidneys are not working as well as they should and further investigation is warranted.
- a second urine test for those with Type 1 diabetes measures the number of ketones in the urine. Ketones are produced by the body when the pancreas does not produce a sufficient amount of insulin to control body cells in order to allow glucose to enter cells in order to produce energy. The body compensates for the shortage of insulin by turning fat into energy for use by the cells. Ketones are toxic to the body and can cause severe medical complications. While a number of products are known in the art that, to a least some degree, individually fulfil the need for toilet paper or alternative wipes and the need for urine testing for the purpose of self-administered medical screening, the art is devoid of any device or method that combines these necessary activities together in one product.
- Figure 2 is a top view of one embodiment of a personal hygiene wipe with integral urine glucose detection feature in accordance with the present invention
- Figure 3 is a cross-section taken alone line 3-3 in Figure 2;
- Figure 4 is a diagram of one example of a chemical composition used in the present invention.
- Figure 5 illustrates one embodiment of a container for the personal hygiene wipe with integral urine glucose detection feature in accordance with the present invention.
- FIG. 2 is a top view of one embodiment of the personal hygiene wipe 200 of the present invention.
- the wipe includes a substrate 201.
- the substrate is the material which gives the wipe a physical structure and is used to hold urine glucose detection ingredients as will be discussed below.
- Substrate 201 has a top surface 202 and a bottom surface 203 as shown in Figure 3.
- Figure 3 is a cross-section of substrate 201 taken along line 3-3 as shown in
- Thickness 204 of substrate 201 is determined by the material used to form substrate 201 as well as its desired strength and rigidity. By way of example only, such thickness can range from 0.0254 to 0.254 millimeters.
- Substrate 201 can be formed of a number of materials that are known in the art, including cotton, polyester, wood pulp and viscose.
- Cotton is soft to the touch and has liquid-absorbing and retaining properties.
- Polyester is made of plastic fiber and is known to have good strength.
- Wood pulp provides a wipe with a high surface area and a flat ribbon-like morphology which gives it high absorbency properties.
- Viscos is a type of rayon fabric made from wood pulp and has good absorbency, high strength and good softness. Other materials that are known in the art may be used as well.
- substrate 201 is depicted as being generally rectangular in construction. However, the invention is not limited thereto. Substrate 201 may be formed in other shapes that are consistent with the objectives of the invention. Substrate 201 may be of a size that makes it convenient for packing a plurality of wipes in a user-friendly commercial wipes container for easy carrying and dispensing. Such a container is illustrated in Figure 5. By way of example only, subtract 201 may have size of 4 inches by 8 inches.
- substrate 201 is saturated in a liquid comprising the active ingredients:
- the above ingredients may also be express by activity level as follows: Glucose Oxidase - 1.875 * 10 L -10 mol/wt activity - lOOU/mg
- glucose in the urine which is above a predetermined level reacts with oxygen and water and is catalyzed by glucose oxidase to give gluconic acid and hydrogen peroxide.
- the hydrogen peroxide then oxidizes iodide ions to iodine, catalyzed by catalase.
- the iodine then forms a matrix with starch to produce a blue-black color to indicate to the user the present of glucose in the urine.
- Figure 4 is the structural formula of the above indigents.
- the first step detects glucose in the urine. This is the reaction of D-glucose with oxygen and water via glucose oxidase to produce D- gluconic acid and hydrogen peroxide.
- Glucose oxidase is an enzyme that is highly specific to glucose and will generally only catalyze this specific reaction:
- the second step is where the indication of test results occurs.
- the hydrogen peroxide produced in step one is catalytically decomposed via the enzyme catalase into water and oxygen.
- the iodide ions likely donate electrons to this process, oxidizing to iodine solid.
- the iodine is then trapped inside the folds of the starch molecules producing the blue-black colour observed.
- glucose in urine is called glycosuria or glucosuria.
- glucose is not usually found in urine.
- glucose can still be present in urine and range between 0 to 0.8 mmol/1 (0 to 15 mg/dL) and still be considered normal.
- the color change in the wipe of the present invention is designed to be triggered by a glucose level above 25mg/dl.
- the substrate of the wipe of the present invention can be made of a material that is soft to the touch and has liquid- absorbing quantities.
- the wipe may be used by females to clean the vaginal area after urination and by males to clean the head of the penis as well. Accordingly, any glucose in the urine will cause the color of the wipe to change, thus indicating the presence of glucose.
- the present invention provides a safe and convenient self-administered medical screening tool where the presence of glucose in urine is indicative of a possible medical condition.
- the wipe of the invention may be used solely for the vaginal area or penis. In addition, it may also be used by males and females for cleaning the anus area after a bowel movement. When used in this way, the wipe of the invention provides both bathroom hygiene and self-administered medical screening using the same product. While the foregoing specification teaches the principles of the present invention, with examples provided for the purpose of illustration, it will be appreciated by one skilled in the art from reading this disclosure that various changes in form and detail can be made without departing from the true scope of the invention.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Abstract
A personal hygiene wipe with an integral urine glucose detection feature. The wipe includes a substrate that is adapted for impregnation with a composition having one or more drying, cleaning, odor control, or antibacterial properties. The wipe also is saturated with a chemical composition for detecting glucose in urine. When glucose is detected, the wipe turns to a different color.
Description
PERSONAL HYGIENE WIPE WITH
INTEGRAL URINE GLUCOSE DETECTION FEATURE CROSS-REFERENCE TO RELATED APPLICATION
This application claims priority to provisional application serial number 63/172,784 filed on April 9, 2021 and entitled “SaveALife - Diabetic Toilet Paper. SaveALife: Diabetic Toilet Paper/Wipe is a toilet paper for female diabetics, used after urinating which will change color if the user has abnormal glucose levels in their urine. It is a rapid glucose test in toilet paper form”. Said application is incorporated herein by reference.
TECHNICAL FIELD
The present invention generally relates to the fields of bathroom hygiene and self-administered medical screening. More particularly, the invention is directed to a personal hygiene wipe with an integral urine glucose detection feature. BACKGROUND OF THE INVENTION
The need for bathroom hygiene is as old as mankind and throughout history that need has been satisfied in accordance with local custom, social hierarchy and the availability of natural tools and material. The early days of wiping with stones, seashells and animal fur progressed through leaves and plants to modem-day specially engineered toilet paper, and now toilet wipes.
While men and women typically use toilet paper, or a suitable wipe, after a bowel movement, many women also use toilet paper after urinating as part of their normal hygiene regiment. In additional to hygiene, wiping the vaginal area after urination is an important step in the prevention of urinary tract infections for women. Proper bathroom hygiene is especially important for women, given the female urethral opening’s close proximity to the rectum and the absence of a female appendage to aim the flow of urine away from the body as is the case with males. If the vaginal area is not cleaned after urination, urine droplets will accumulate in the pubic region and be transferred to undergarments. In addition to causing odor, the accumulation of urine creates a breeding ground for bacteria which increases the risk of a urinary tract infection in females.
It is also noted that it is nearly impossible for a human to have a bowel movement without also passing some amount of urine. One can urine without having a bowel movement, but usually not the other way around. This has to do with how the larger circular muscles around the anus involuntarily flex and interact with the much smaller circular muscles around the urethra during a bowel movement in both men and women. Thus, every bowel movement will require toilet paper or a toilet wipe to clean the anal area and in the case of women, the vaginal area to dry any residual urine. Research and numerous surveys show that proper bathroom hygiene is not always observed by most women and not at all by some. While there is better adherence to proper hygiene following a bowel movement, adherence drops off when voiding only urine. Thus, many women do not dry their vaginal area after urination
and rely on their underwear to catch the residue. Doing so, however, is a bad practice as it increases the risk of a urinary tract infection as explained above.
Toilet paper is readily available virtually everywhere, biodegrades quickly and efficiently, and does not damage pipelines, sewage systems, and water treatment centers.
While traditional toilet paper has its advantages, it has disadvantages as well. A noted disadvantage is that in order to achieve a thorough cleaning, many users use more paper than necessary. In addition, the white color of toilet paper is often the result of it being bleached with chlorine which can produce a harmful chemical by- product known as dioxin.
Thus, wipes are increasingly being used as an alternative to toilet paper. As there currently is no recognized standard, wipes come in a variety of sizes, shape and constructions depending on brand and marketing strategy.
Wipes have the advantage of being sturdier than toilet paper and their moistness helps in the cleaning process which results in a greater sense of feeling clean. However, poorly designed flushable wipes create problems for sewer pipes and water treatment systems and for the environment as well.
Wet wipes are said to be a major factor in the creation of fatbergs. Fatbergs are larges masses of non-biodegradable solid waste in a sewage system. They are formed of congealed fat and personal hygiene products that have been flushed down toilets.
With respect to the environment, plastic is a common material used to make many flushable wipes. When the wipes break down after being flushed down the
toilet or otherwise discarded, they release microplastics into the water or ground which find their way into the food system and ultimately into the human body. In addition, there is the adverse impact of plastic pollution on marine life.
As mentioned above, the present invention also relates to the field of self- administered medical screening.
Health care has many stakeholders, including patients, healthcare provides, insurance companies and of course governments. In the United States, the majority of health care services are delivered through private entities as the U.S. does not have a universal health care system. In many cases, governments ultimately bear a great deal of the cost of health care. Through its regulatory powers, governments also control many aspects of health care accessibility and delivery.
While every stakeholder strives for the best healthcare possible for its constitutes, each stakeholder also has its own particular interest to protect, often at the expense of other stakeholders. Thus, the natural tension between health care stakeholders often leaves many of the weakest stakeholders, i.e., patients, without adequate healthcare care or no health care at all. Thus, more of the health care burden is increasingly being placed on the end user of health care services.
For example, vigilance of health care needs is increasingly being placed on individuals through better diet, more physical exercise and more attention to the signs and signals that the human body provides that indicate a potential health care problem. For example, high blood pressure is the body’s way of signaling that one’s cardiovascular system is in need of attention. A rapid heart rate that is unrelated to
physical exercise and an irregular heart beat are others. These conditions are all detectable in the first instance by a person using readily available over the counter diagnostic devices and do not require a lab or doctor’s visit. However, a doctor’s visit is often required, or at least recommended, to confirm the condition and provide subsequent treatment.
Other signs of a person’s health are concealed in body fluids such as blood and urine. So-called blood work and a urine test are sacrosanct to virtually every medical diagnosis.
One’s blood chemistry is particular informing as to a person’s state of health. The kidneys remove fluids, waste products and other substances from the blood.
Thus, an analysis of the urine can reveal many important clues as to a person’s health. Urinalysis is especially important in detecting urinary tract infections, chronic kidney disease and in monitoring diabetes.
Diabetes is a chronic health condition that affects how the human body turns food into energy.
As shown in Figure 1, the stomach (Block 102) breaks down most of the food (Block 101) we eat into sugar, i.e., glucose. The stomach and small intestines (Block 103) absorb the glucose and then releases it into bloodstream 104.
Bloodstream 104 carries the glucose to the cells (Block 107) of the body for immediate conversion to energy if energy is currently needed. Block 107 is a representative cell of all of the cells in the body for purposes of this explanation.
If energy is not currently needed, the glucose is stored in the body (Block 106) until it is needed by the cells in order to produce energy.
The pancreas (Block 105) monitors the bloodstream and produces insulin in proportion to the amount of glucose present in the bloodstream. As shown in Figure 1, insulin is the trigger which controls switch 108 inside the cell that allow glucose from the bloodstream to actually enter the cell for conversion to energy. Without insulin, the switch does not open and no glucose is allowed to enter the cell.
As mentioned above. Block 107 is a representative of all cells in the human body, thus each cell has a corresponding switch 108.
When the pancreas does not make a sufficient amount of insulin or the body cannot use all of the insulin the pancreas produces, the excess glucose, i.e., blood sugar, remains in bloodstream 104. This condition is known as diabetes and can lead to severe medication complications if not treated.
There are two primary types of diabetes, Type 1 and Type 2. People with Type 1 diabetes do not produce insulin and people with Type 2 diabetes do not respond to insulin as well as they should. Diabetes treatment regiments often require constant monitoring of blood sugar. An analysis of the blood is often used for this purpose. Such an analysis usually requires a visit to a doctor’s office or to a lab for blood to be drawn and analyzed. There are also over the counter consumer grade blood sugar monitors that can be purchased as well. Analysis of the urine can also be used to monitor a diabetic condition. One such urine test measures the amount of a protein in the urine called microalbuminuria. This test detects when small amounts of albumin, the main protein in the blood, has found its way into the urine. This condition is indictive of kidney disease which can
lead to kidney damage and eventually to kidney failure. Thus, the presence of albumin in the urine suggest that the kidneys are not working as well as they should and further investigation is warranted.
A second urine test for those with Type 1 diabetes measures the number of ketones in the urine. Ketones are produced by the body when the pancreas does not produce a sufficient amount of insulin to control body cells in order to allow glucose to enter cells in order to produce energy. The body compensates for the shortage of insulin by turning fat into energy for use by the cells. Ketones are toxic to the body and can cause severe medical complications. While a number of products are known in the art that, to a least some degree, individually fulfil the need for toilet paper or alternative wipes and the need for urine testing for the purpose of self-administered medical screening, the art is devoid of any device or method that combines these necessary activities together in one product.
The present invention meets this need. BRIEF DESCRIPTION OF THE DRAWINGS
The novel features of the present invention are set out with particularity in the appended claims, but the invention will be understood more fully and clearly from the following detailed description of the invention as set forth in the accompanying drawings in which: Figure 1 block diagram of how the humane body digests food into glucose and how glucose enters body cells;
Figure 2 is a top view of one embodiment of a personal hygiene wipe with integral urine glucose detection feature in accordance with the present invention;
Figure 3 is a cross-section taken alone line 3-3 in Figure 2;
Figure 4 is a diagram of one example of a chemical composition used in the present invention; and
Figure 5 illustrates one embodiment of a container for the personal hygiene wipe with integral urine glucose detection feature in accordance with the present invention.
DESCRIPTION OF THE PREFERRED EMBODIMENT
An example embodiment of the present invention will now be described with reference to the accompanying drawings. Figure 2 is a top view of one embodiment of the personal hygiene wipe 200 of the present invention. The wipe includes a substrate 201. The substrate is the material which gives the wipe a physical structure and is used to hold urine glucose detection ingredients as will be discussed below. Substrate 201 has a top surface 202 and a bottom surface 203 as shown in Figure 3. Figure 3 is a cross-section of substrate 201 taken along line 3-3 as shown in
Figure 2. Thickness 204 of substrate 201 is determined by the material used to form substrate 201 as well as its desired strength and rigidity. By way of example only, such thickness can range from 0.0254 to 0.254 millimeters.
Substrate 201 can be formed of a number of materials that are known in the art, including cotton, polyester, wood pulp and viscose. Cotton is soft to the touch and has liquid-absorbing and retaining properties. Polyester is made of plastic fiber and is known to have good strength. Wood pulp provides a wipe with a high surface area and a flat ribbon-like morphology which gives it high absorbency properties. Viscos
is a type of rayon fabric made from wood pulp and has good absorbency, high strength and good softness. Other materials that are known in the art may be used as well.
As show in Figure 2, substrate 201 is depicted as being generally rectangular in construction. However, the invention is not limited thereto. Substrate 201 may be formed in other shapes that are consistent with the objectives of the invention. Substrate 201 may be of a size that makes it convenient for packing a plurality of wipes in a user-friendly commercial wipes container for easy carrying and dispensing. Such a container is illustrated in Figure 5. By way of example only, subtract 201 may have size of 4 inches by 8 inches.
In order to complete construction of wipe 200, substrate 201 is saturated in a liquid comprising the active ingredients:
Glucose oxidase enzyme;
Catalase enzyme;
Iodide salt; and
Starch.
Alternatively, the following ingredients can be used:
Glucose Oxidase enzyme; and
An Anthocyanin.
The proportions of each ingredient by mole weight are as follows:
Glucose Oxidase - 1.875 * 10L-10 mol/wt
Catalase - 1.563 * 10L- 11 mol/wt
Potassium Iodide - 6.024 * 10L-4 mol/wt
Starch - -7.401 * 10L-7 mol/wt
Benzoic Acid - 4.094 * 10L-5 mol/wt **
** Made up to a pH of 5 with 6.4886 * 10L-6 mol/wt of NaOH
The above ingredients may also be express by activity level as follows: Glucose Oxidase - 1.875 * 10L-10 mol/wt activity - lOOU/mg
Catalase - 1.563 * 10L- 11 mol/wt activity - ~30,000U/mL Potassium Iodide - 6.024 * 10L-4 mol/wt Starch - -7.401 * 10L-7 mol/wt 5 Benzoic Acid - 4.094 * 10L-5 mol/wt ** ** Made up to a pH of 5 with 6.4886 * 10L-6 mol/wt of NaOH
When the wipe of the invention comes into contact with urine, glucose in the urine which is above a predetermined level reacts with oxygen and water and is catalyzed by glucose oxidase to give gluconic acid and hydrogen peroxide. The hydrogen peroxide then oxidizes iodide ions to iodine, catalyzed by catalase. The iodine then forms a matrix with starch to produce a blue-black color to indicate to the user the present of glucose in the urine.
Figure 4 is the structural formula of the above indigents.
With reference to Figure 4, the first step detects glucose in the urine. This is the reaction of D-glucose with oxygen and water via glucose oxidase to produce D- gluconic acid and hydrogen peroxide. Glucose oxidase is an enzyme that is highly specific to glucose and will generally only catalyze this specific reaction:
(D-Glucose+2H20+02 Glucose Oxidase D-Gluconic Acid+2H202 )
The second step is where the indication of test results occurs. The hydrogen peroxide produced in step one is catalytically decomposed via the enzyme catalase into water and oxygen. The iodide ions likely donate electrons to this process, oxidizing to iodine solid. The iodine is then trapped inside the folds of the starch molecules producing the blue-black colour observed.
(2H202 + 2H+ + 2e — > 2H20)
The presence of glucose in urine is called glycosuria or glucosuria. In a healthy person, glucose is not usually found in urine. However, glucose can still be present in urine and range between 0 to 0.8 mmol/1 (0 to 15 mg/dL) and still be considered normal. The color change in the wipe of the present invention is designed to be triggered by a glucose level above 25mg/dl.
Applicant has found that it takes only a few drops of urine for the inventive wipe to react and product a color change in the presence of glucose in the urine above the normal range. As pointed out above, the substrate of the wipe of the present invention can be made of a material that is soft to the touch and has liquid- absorbing quantities. Thus, the wipe may be used by females to clean the vaginal area after urination and by males to clean the head of the penis as well. Accordingly, any glucose in the urine will cause the color of the wipe to change, thus indicating the presence of glucose. The present invention provides a safe and convenient self-administered medical screening tool where the presence of glucose in urine is indicative of a possible medical condition. The services of a medical professional can then be sought for follow-up and further analysis of the condition.
The wipe of the invention may be used solely for the vaginal area or penis. In addition, it may also be used by males and females for cleaning the anus area after a bowel movement. When used in this way, the wipe of the invention provides both bathroom hygiene and self-administered medical screening using the same product. While the foregoing specification teaches the principles of the present invention, with examples provided for the purpose of illustration, it will be appreciated by one skilled in the art from reading this disclosure that various changes in form and detail can be made without departing from the true scope of the invention.
Claims
1. A hygiene wipe, said wipe comprising: a substrate adapted for impregnation with a composition having one or more drying, cleaning, odor control, or antibacterial properties; and a chemical composition for detecting glucose in urine, wherein said substrate is impregnated with said composition.
2. The hygiene wipe of claim 1, wherein said substrate is made of a material selected from the group consisting of cotton, polyester, wood pulp and viscose.
3. The hygiene wipe of claim 1, wherein when said wipe is subjected to glucose in urine, at least a portion of said wipe changes to a different color.
4. The hygiene wipe of claim 3, wherein said change in color persist after said wipe is no longer subjected to glucose.
5. The hygiene wipe of claim 1, wherein said composition is comprised of the ingredients of catalase enzyme, iodide salt, starch and benzoic acid.
6. The hygiene wipe of claim 5, wherein the proportion of said catalase enzyme in said composition by mole weight is 1.875 * 10L-10 mol/wt.
7. The hygiene wipe of claim 6, wherein the proportion of said iodide salt in said composition by mole weight is 1.563 * 10L-11 mol/wt.
8. The hygiene wipe of claim 7, wherein the proportion of said starch in said composition by mole weight is -7.401 * 10L-7 mol/wt.
9. The hygiene wipe of claim 8, wherein the proportion of said benzoic acid in said composition by mole weight is 4.094 * 10L-5 mol/wt.
10. The hygiene wipe of claiml, wherein said composition is comprised of the ingredients of glucose oxidase enzyme and anthocyanin.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163172784P | 2021-04-09 | 2021-04-09 | |
US63/172,784 | 2021-04-09 | ||
US17/472,971 US20220323311A1 (en) | 2021-04-09 | 2021-09-13 | Personal hygiene wipe with integral urine glucose detection feature |
US17/472,971 | 2021-09-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2022214876A2 true WO2022214876A2 (en) | 2022-10-13 |
WO2022214876A3 WO2022214876A3 (en) | 2022-11-17 |
Family
ID=83006206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2022/000198 WO2022214876A2 (en) | 2021-04-09 | 2022-04-08 | Personal hygiene wipe with integral urine glucose detection feature |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022214876A2 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2855292B2 (en) * | 1991-04-05 | 1999-02-10 | 株式会社大貴 | Sheets |
US20070027383A1 (en) * | 2004-07-01 | 2007-02-01 | Peyser Thomas A | Patches, systems, and methods for non-invasive glucose measurement |
DE202007016404U1 (en) * | 2007-10-30 | 2009-03-12 | Kopp, Klaus F., Prof. Dr. | Hygiene paper with indicator |
GB2469496B (en) * | 2009-04-16 | 2013-07-17 | Aim Straight Ltd | Urinary device |
GB201113880D0 (en) * | 2011-08-12 | 2011-09-28 | Archimed Llp | Novel compositions |
US20180003716A1 (en) * | 2016-06-29 | 2018-01-04 | John P. Studdiford | Devices for detection of an analyte in urine and methods of using same |
-
2022
- 2022-04-08 WO PCT/IB2022/000198 patent/WO2022214876A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2022214876A3 (en) | 2022-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Black et al. | MASD part 2: incontinence-associated dermatitis and intertriginous dermatitis: a consensus | |
US9107776B2 (en) | Incontinence management system and diaper | |
Ahmed | Prevalence of chronic complications and associated factors in type 2 diabetes | |
KR101596003B1 (en) | Urinary device | |
CA2685889C (en) | Moisture monitoring system | |
US20060025732A1 (en) | Sanitary article for revealing and observating personally physiological condition | |
US20130296739A1 (en) | Diaper with Pocket for an Absorbent Pad Containing a Test Strip | |
TW200423914A (en) | Delayed dispersion interlabial absorbent article | |
US20220323311A1 (en) | Personal hygiene wipe with integral urine glucose detection feature | |
WO2022214876A2 (en) | Personal hygiene wipe with integral urine glucose detection feature | |
Fonda et al. | Urinary incontinence and bladder dysfunction in older persons | |
TWI334345B (en) | ||
Ouslander | Intractable incontinence in the elderly | |
Baillie et al. | Meeting elimination needs | |
Thompson et al. | Continence restoration in the cognitively impaired adult | |
Konstantinidis et al. | Urinary tract infections in neuro-patients | |
AU2007201952C1 (en) | Incontinence management system and diaper | |
Grainger | Enhancing empathy through experiential learning—managing incontinence. 2/2 | |
Getliffe et al. | Catheters and containment products | |
Ripley | Skin care in patients with urinary of faecal incontinence. | |
Leaver | Meeting personal needs: elimination | |
US20220054327A1 (en) | Device For Male Urinary Incontinence | |
Mainstone | Maintaining infant skin health and hygiene | |
Metcalf et al. | Chronic diarrhoea: investigation, treatment and nursing care | |
Bianchi | Practice development Innovations Practice development |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22758003 Country of ref document: EP Kind code of ref document: A2 |